Clinical Trial Update: A Study on the Efficacy and Safety of Bevacizumab in Untreated Patients With Locally Advanced Cervical Cancer [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update assessing bevacizumab's efficacy and safety in untreated locally advanced cervical cancer across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Air Force Military Medical University, China | Conditions: Disease Free Survival | Phase 2, Phase 3 | Status: UNKNOWN